Table 3: Summary of previous studies testing benign nevi and primary melanomas using the same FISH probe set. Sensitivity and specificity refer to pathologic diagnosis as a gold standard.
| Study | # of cases | Sensitivity | Specificity |
| Gerami et al. [3] | 169 (86 benign, 83 melanoma, 27 ambiguous) |
87% | 96% |
| Morey et al. [5] | 40 (20 benign, 20 melanoma) | 90% | 95% |
| Newman et al. [6] | 78 (36 benign, 42 melanoma) | 81% | 100% |
| Gerami et al. [4,11] | 233 (110 benign, 123 melanoma) | 83% | 94% |
| Vergier et al. [9] | 138 (20 benign, 23 melanoma, 95 ambiguous) |
85% | 90% |
| Gaiser et al. [8] | 22 (3 benign, 7 melanoma, 12 ambiguous) |
50% | 100% |
| Gerami et al. [7] | 102 (51 nevi, 51 melanoma) | 75% | 96% |
| Gerami et al. [7] Gerami criteria |
102 (51 nevi, 51 melanoma) | 94% | 98% |
| Fang et al. [14] | 115 (50 nevi, 50 primary melanoma, 15 metastatic melanoma) |
84% | 98% |